A

Agios (AGIO)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Agios (AGIO)

Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more

Open
USD36.71
High
USD38.09
Low
USD36.60
52 Week High
USD62.58
Monthly Return
5.70%
Revenue
37M

Daily Vol.
165.09k
Avg. Daily Vol.
579.84k
Market Cap.
2.1B
52 Week Low
23.42
Annual Return
-11.90%

Stock News

Foresight: Eye-Net, in Collaboration with Orange’s Mobile Application, Achieves 99% Detection Rate in French Urban Mobility Trials

Foresight: Eye-Net, in Collaboration with Orange’s Mobile Application, Achieves 99% Detection Rate in French Urban Mobility Trials

Yahoo

This early-warning indicator is telling the stock market that a recession is more likely

This early-warning indicator is telling the stock market that a recession is more likely

MarketWatch

What If Mistras Isn't As Broken As It Looks?

What If Mistras Isn't As Broken As It Looks?

SeekingAlpha

Boeing: Leadership Changes And A Warning For The Bulls

Boeing: Leadership Changes And A Warning For The Bulls

SeekingAlpha

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.